Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling

Status Completed

Clinical Trial Summary

Aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes.

Clinical Trial Description

Epiretinal membranes (ERM) are disorders leading to vision loss and metamorphopsia. Vitrectomy with membrane peeling has developed to be the gold-standard in treatment of ERM. Nevertheless, there are about 10% of patients having intraretinal cystoid changes after surgery with potential for disturbance of visual acuity. The aim of the study is to assess the rate of postoperative intraretinal cystoid changes after pars plana vitrectomy with membrane peeling and peribulbar application of triamcinolone acetonide and to examine possible risk factors for postoperative intraretinal cystoid changes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04472039
Study type	Observational
Source	Vienna Institute for Research in Ocular Surgery
Contact
Status	Completed
Phase
Start date	June 30, 2020
Completion date	September 28, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03559491` - Dexamethasone Intravitreal Implant in Retinal Vein Occlusion
Completed	`NCT00105027` - The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study	Phase 3
Completed	`NCT01546402` - Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema	Phase 4
Completed	`NCT00106132` - Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage	Phase 3
Completed	`NCT00335439` - Effect of Prophylactic Ketorolac on CME After Cataract Surgery	N/A
Terminated	`NCT02665689` - Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab	Phase 4
Completed	`NCT01698749` - Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema	N/A
Completed	`NCT00000115` - Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema	Phase 2
Withdrawn	`NCT00135655` - A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema	Phase 2
Completed	`NCT00001738` - Vascular Endothelial Growth Factor (VEGF) in Uveitis	N/A